Cargando…
Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma
Cell cycle deregulation is involved in the pathogenesis of many cancers and is often associated with protein kinase aberrations, including the polo-like kinase 1 (PLK1). We used retinoblastoma, an intraocular malignancy that lacks targeted therapy, as a disease model and set out to reveal targetabil...
Autores principales: | Ma, Huan, Nie, Cong, Chen, Ying, Li, Jinmiao, Xie, Yanjie, Tang, Zhixin, Gao, Yang, Ai, Siming, Mao, Yuxiang, Sun, Qian, Lu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420894/ https://www.ncbi.nlm.nih.gov/pubmed/33573708 http://dx.doi.org/10.3727/096504021X16130322409507 |
Ejemplares similares
-
Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)
por: Monfort-Vengut, Ana, et al.
Publicado: (2023) -
ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines
por: Prasad, Anil, et al.
Publicado: (2016) -
Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle
por: Yang, Jie, et al.
Publicado: (2021) -
Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein
por: Mukhopadhyay, Nishit K., et al.
Publicado: (2017) -
Association of p53 rs1042522, MDM2 rs2279744, and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population
por: Chen, Rongxin, et al.
Publicado: (2015)